1
|
Chhabra S, Mehan S, Khan Z, Gupta GD, Narula AS. Matrine mediated neuroprotective potential in experimental multiple sclerosis: Evidence from CSF, blood markers, brain samples and in-silico investigations. J Neuroimmunol 2023; 384:578200. [PMID: 37774554 DOI: 10.1016/j.jneuroim.2023.578200] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/09/2023] [Accepted: 09/12/2023] [Indexed: 10/01/2023]
Abstract
Multiple sclerosis (MS) is a debilitating, inflammatory, and demyelinating disease of the central nervous system influenced by environmental and genetic factors. Around 2.8 million people worldwide are affected by MS due to its challenging diagnosis and treatment. Our study investigates the role of the JAK/STAT and PPAR-gamma signaling pathways in the progression of multiple sclerosis. Inflammation and demyelination can be caused by dysregulation of these pathways. Modulating the STAT-3, mTOR, and PPAR-gamma signaling pathways may offer therapeutic potential for multiple sclerosis. Matrine (40 and 80 mg/kg, i.p.), a quinolizidine alkaloid derived from Sophora flavescens, has been investigated for its therapeutic potential in our laboratory. Matrine has been studied for its neuroprotective effect in neurodegenerative diseases. It inhibits inflammatory responses and promotes regeneration of damaged myelin sheaths, indicating its potential efficacy in treating multiple sclerosis. Matrine exerts its neuroprotective effect by inhibiting STAT-3 and mTOR and promoting PPAR-gamma expression.GW9662, a PPAR-gamma antagonist (2 mg/kg, i.p.), was administered to evaluate the involvement of PPAR-gamma and to compare the efficacy of matrine's potential neuroprotective effect. Matrine's interaction with the STAT-3, mTOR, and PPAR-gamma pathways in multiple Sclerosis was also validated and confirmed through insilico investigation. In addition, matrine altered the CBC profile, intensifying the clinical presentation of multiple sclerosis. In addition, we evaluated the diagnostic potential of various biological samples, including CSF, blood plasma, and brain homogenates (striatum, cortex, hippocampus, and midbrain). These samples were used to evaluate the neurochemical changes caused by neurobehavioral alterations during the progression of multiple sclerosis. These results indicate that matrine treatment ameliorated multiple sclerosis and that the mechanism underlying these effects may be closely related to the modulation of the STAT-3/mTOR/PPAR-gamma signaling pathway.
Collapse
Affiliation(s)
- Swesha Chhabra
- Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India
| | - Sidharth Mehan
- Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India.
| | - Zuber Khan
- Division of Neuroscience, Department of Pharmacology, ISF College of Pharmacy, Moga, Punjab, India
| | | | - Acharan S Narula
- Narula Research, LLC, 107 Boulder Bluff, Chapel Hill, NC 27516, USA
| |
Collapse
|
2
|
Assis CRD, Linhares AG, Cabrera MP, Oliveira VM, Silva KCC, Marcuschi M, Maciel Carvalho EVM, Bezerra RS, Carvalho LB. Erythrocyte acetylcholinesterase as biomarker of pesticide exposure: new and forgotten insights. ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH INTERNATIONAL 2018; 25:18364-18376. [PMID: 29797194 DOI: 10.1007/s11356-018-2303-9] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/22/2017] [Accepted: 05/11/2018] [Indexed: 06/08/2023]
Abstract
Acetylcholinesterase (AChE) acts on the hydrolysis of acetylcholine, rapidly removing this neurotransmitter at cholinergic synapses and neuromuscular junctions as well as in neuronal growth and differentiation, modulation of cell adhesion ("electrotactins") and aryl-acylamidase activity (AAA). This enzyme is also found in erythrocyte, as 160 kDa dimer that anchors to the plasma membrane via glycophosphatidylinositol. The function of this enzyme in erythrocytes has not yet been elucidated; however, it is suspected to participate in cell-to-cell interactions. Here, a review on erythrocyte AChE characteristics and use as biomarker for organophosphorus and carbamate insecticides is presented since it is the first specific target/barrier of the action of these pesticides, besides plasma butyrylcholinesterase (BChE). However, some past and current methods have disadvantages: (a) not discriminating the activities of AChE and BChE; (b) low accuracy due to interference of hemoglobin in whole blood samples. On the other hand, extraction methods of hemoglobin-free erythrocyte AChE allows: (a) the freezing and transporting of samples; (b) samples free of colorimetric interference; (c) data from only erythrocyte AChE activity; (d) erythrocyte AChE specific activity presents higher correlation with the central nervous system AChE than other peripheral ChEs; (e) slow spontaneous regeneration against anti-ChEs agents of AChE in comparison to BChE, thus increasing the chances of detecting such compounds following longer interval after exposure. As monitoring perspectives, hemoglobin-free methodologies may be promising alternatives to assess the degree of exposure since they are not influenced by this interfering agent.
Collapse
Affiliation(s)
- Caio R D Assis
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil.
| | - Amanda G Linhares
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Mariana P Cabrera
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Vagne M Oliveira
- Laboratório de Tecnologia de Produtos Bioativos, Departamento de Morfologia e Fisiologia Animal, DMFA, Universidade Federal Rural de Pernambuco, Recife, Pernambuco, Brazil
| | - Kaline C C Silva
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
- Universidade Estadual da Bahia, Paulo Afonso, Bahia, Brazil
| | - Marina Marcuschi
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Elba V M Maciel Carvalho
- Laboratório de Glicoproteínas, Departamento de Bioquímica, Universidade Federal de Pernambuco, Recife, PE, Brazil
| | - Ranilson S Bezerra
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| | - Luiz B Carvalho
- Laboratório de Enzimologia - LABENZ, Departamento de Bioquímica and Laboratório de Imunopatologia Keizo Asami - LIKA, Universidade Federal de Pernambuco, Recife, Pernambuco, 50670-901, Brazil
| |
Collapse
|